申请人:Pfizer Inc.
公开号:US20040092520A1
公开(公告)日:2004-05-13
Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
1
本文描述了化学式为(I)的化合物,它们作为大麻素受体配体,并且在动物中治疗与大麻素受体介导的疾病相关的用途。